|
1
|
Abuissa H, O'Keefe JH and Bybee KA:
Statins as anti-arrhythmics: a systematic review part II: effects
on risk of ventricular arrhythmias. Clin Cardiol. 32:549–552. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma YX, Li WH and Xie Q: Rosuvastatin
inhibits TGF-beta1 expression and alleviates myocardial fibrosis in
diabetic rats. Pharmazie. 68:355–358. 2013.PubMed/NCBI
|
|
3
|
Paraskevaidis IA, Iliodromitis EK,
Ikonomidis I, et al: The effect of acute administration of statins
on coronary microcirculation during the pre-revascularization
period in patients with myocardial infraction. Atherosclerosis.
223:184–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hayashidani S, Tsutsui H, Shiomi T, et al:
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase
inhibitor, attenuates left ventricular remodeling and failure after
experimental myocardial infarction. Circulation. 105:868–873. 2002.
View Article : Google Scholar
|
|
5
|
Jiang BH, Tardif JC, Sauvageau S, et al:
Beneficial effects of atorvastatin on lung structural remodeling
and function in ischemic heart failure. J Card Fail. 16:679–688.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allessie M, Ausma J and Schotten U:
Electrical, contractile and structural remodeling during atrial
fibrillation. Cardiovasc Res. 54:230–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pinho-Gomes AC, Reilly S, Brandes RP and
Casadei B: Targeting inflammation and oxidative stress in atrial
fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a
reductase inhibition with statins. Antioxid Redox Signal.
20:1268–1285. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumagai K, Nakashima H and Saku K: The
HMG-CoA reductase inhibitor atorvastatin prevents atrial
fibrillation by inhibiting inflammation in a canine sterile
pericarditis model. Cardiovasc Res. 62:105–111. 2004. View Article : Google Scholar
|
|
9
|
Aronson D, Mutlak D, Bahouth F, et al:
Restrictive left ventricular filling pattern and risk of new-onset
atrial fibrillation after acute myocardial infarction. Am J
Cardiol. 107:1738–1743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McCarty MF: Practical prevention of
cardiac remodeling and atrial fibrillation with full-spectrum
antioxidant therapy and ancillary strategies. Med Hypotheses.
75:141–147. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alasady M, Shipp NJ, Brooks AG, et al:
Myocardial infarction and atrial fibrillation: importance of atrial
ischemia. Circ Arrhythm Electrophysiol. 6:738–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bode F, Katchman A, Woosley RL and Franz
MR: Gadolinium decreases stretch-induced vulnerability to atrial
fibrillation. Circulation. 101:2200–2205. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang J, Xu Y, Pan L, Chen T, Chen Z and
Zhao R: Effect of simvastatin on collagen I deposition in
non-infarcted myocardium: role of NF-κB and osteopontin. Can J
Physiol Pharmacol. 88:1026–1034. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin YM, Ye P, He JQ, Sheng L, Wang LY and
Du J: Simvastatin inhibited cardiac hypertrophy and fibrosis in
apolipoprotein E-deficient mice fed a ‘Western-style diet’ by
increasing PPAR α and γ expression and reducing TC, MMP-9, and Cat
S levels. Acta Pharmacol Sin. 31:1350–1358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shyu KG, Wang BW, Chen WJ, Kuan P and Hung
CR: Mechanism of the inhibitory effect of atorvastatin on endoglin
expression induced by transforming growth factor-beta1 in cultured
cardiac fibroblasts. Eur J Heart Fail. 12:219–226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai CT, Lai LP, Kuo KT, et al:
Angiotensin II activates signal transducer and activators of
transcription 3 via Rac1 in atrial myocytes and fibroblasts:
implication for the therapeutic effect of statin in atrial
structural remodeling. Circulation. 117:344–355. 2008. View Article : Google Scholar
|
|
17
|
Briones AM, Rodriguez-Criado N, Hernanz R,
et al: Atorvastatin prevents angiotensin II-induced vascular
remodeling and oxidative stress. Hypertension. 54:142–149. 2009.
View Article : Google Scholar : PubMed/NCBI
|
